These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 3494080)
21. Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1. Kirschfink M; Blase L; Engelmann S; Schwartz-Albiez R J Immunol; 1997 Feb; 158(3):1324-31. PubMed ID: 9013976 [TBL] [Abstract][Full Text] [Related]
22. Regulation of the function of the first component of complement by human C1q receptor. van den Berg RH; Faber-Krol M; van Es LA; Daha MR Eur J Immunol; 1995 Aug; 25(8):2206-10. PubMed ID: 7664783 [TBL] [Abstract][Full Text] [Related]
23. Human blood platelets possess specific binding sites for C1q. Peerschke EI; Ghebrehiwet B J Immunol; 1987 Mar; 138(5):1537-41. PubMed ID: 3492557 [TBL] [Abstract][Full Text] [Related]
24. Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures. Szabó J; Cervenák L; Tóth FD; Prohászka Z; Horváth L; Kerekes K; Beck Z; Bácsi A; Erdei A; Peerschke EI; Füst G; Ghebrehiwet B Clin Immunol; 2001 May; 99(2):222-31. PubMed ID: 11318594 [TBL] [Abstract][Full Text] [Related]
25. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1). Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094 [TBL] [Abstract][Full Text] [Related]
26. Characterization of C1q receptor expression on human phagocytic cells: effects of PDBu and fMLP. Bobak DA; Frank MM; Tenner AJ J Immunol; 1986 Jun; 136(12):4604-10. PubMed ID: 3486907 [TBL] [Abstract][Full Text] [Related]
27. Enhancement of human B cell proliferation by an antibody to the C3d receptor, the gp 140 molecule. Frade R; Crevon MC; Barel M; Vazquez A; Krikorian L; Charriaut C; Galanaud P Eur J Immunol; 1985 Jan; 15(1):73-6. PubMed ID: 3155687 [TBL] [Abstract][Full Text] [Related]
28. Functional aspects of the C1q receptors. Tenner AJ Behring Inst Mitt; 1993 Dec; (93):241-53. PubMed ID: 8172573 [TBL] [Abstract][Full Text] [Related]
29. The C1q-R participates in immunoregulation and signal transduction. Ghebrehiwet B; Peerschke EI Behring Inst Mitt; 1993 Dec; (93):236-40. PubMed ID: 8172572 [TBL] [Abstract][Full Text] [Related]
30. The effects of interleukin 1 on human B cell activation and proliferation. Falkoff RJ; Muraguchi A; Hong JX; Butler JL; Dinarello CA; Fauci AS J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846 [TBL] [Abstract][Full Text] [Related]
31. Lymphoblastoid B cell lines produce an interleukin-1-like activity that can be serologically distinct from macrophage interleukin-1. Valentine M; Lotz M; Dinarello CA; Carson DA; Vaughan JH Lymphokine Res; 1986; 5(3):173-83. PubMed ID: 3018386 [TBL] [Abstract][Full Text] [Related]
32. Characterization of C1q-binding material released from the membranes of Raji and U937 cells by limited proteolysis with trypsin. Erdei A; Reid KB Biochem J; 1988 Oct; 255(2):493-9. PubMed ID: 3144267 [TBL] [Abstract][Full Text] [Related]
33. Costimulatory effect of IL-12 on the activation of naive, memory CD4+ T cells, and Th1 clone. Kato T; Morokata T; Igarashi O; Yee ST; Inobe M; Uede T; Azuma M; Okumura K; Nariuchi H Cell Immunol; 1997 Feb; 176(1):50-8. PubMed ID: 9070317 [TBL] [Abstract][Full Text] [Related]
34. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q. Pearlstein E; Sorvillo J; Gigli I J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128 [TBL] [Abstract][Full Text] [Related]
35. C1qRP, the C1q receptor that enhances phagocytosis, is detected specifically in human cells of myeloid lineage, endothelial cells, and platelets. Nepomuceno RR; Tenner AJ J Immunol; 1998 Feb; 160(4):1929-35. PubMed ID: 9469455 [TBL] [Abstract][Full Text] [Related]
36. IL 1-like activity in antigen-presenting human B cell lines. Gerrard TL; Volkman DJ J Immunol; 1985 Nov; 135(5):3217-23. PubMed ID: 2995488 [TBL] [Abstract][Full Text] [Related]
37. Lymphocyte chemotactic activity of human interleukin 1. Miossec P; Yu CL; Ziff M J Immunol; 1984 Oct; 133(4):2007-11. PubMed ID: 6332145 [TBL] [Abstract][Full Text] [Related]
38. Spontaneous release of Fc receptor-like material from human lymphoblastoid cell lines. Molenaar JL; van Galen M; Hannema AJ; Zeijlemaker W; Pondman KW Eur J Immunol; 1977 Apr; 7(4):230-6. PubMed ID: 301094 [TBL] [Abstract][Full Text] [Related]
39. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells. Boackle SA; Morris MA; Holers VM; Karp DR J Immunol; 1998 Dec; 161(12):6537-43. PubMed ID: 9862679 [TBL] [Abstract][Full Text] [Related]
40. The effect of fibronectin on the processing of C1q- and C3b/bi-coated immune complexes by peripheral blood monocytes. Sorvillo JM; Gigli I; Pearlstein E J Immunol; 1986 Feb; 136(3):1023-6. PubMed ID: 3484498 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]